Stocks Explorer
Stocks
Sectors
Search
Neuren Pharmaceuticals Ltd (NEU) News
Profile
Chart
News
Analysis
Holders
NEU price today
by TradingView
Date
Title
Dec 26
An Intrinsic Calculation For Neuren Pharmaceuticals Limited (ASX:NEU) Suggests It's 44% Undervalued
Dec 18
Neuren Phase 2 trial shows significant improvements in Phelan-McDermid syndrome
‹ Prev
Page
of 1
Next ›